Replay available

Redcare Phamacy Unsp/Adr (SAEYY) Q3 2025 Earnings Call

Redcare Phamacy Unsp/Adr (OTC: SAEYY) Q3 2025 earnings conference call, held 2025-10-29. Replay captured from the company's public earnings webcast.

Wed, October 29, 2025 at 5:00 AMendedReplay
Redcare Phamacy  Unsp/Adr (SAEYY) Q3 2025 Earnings Call

Hosted by

Featured presenters

Olof Heinrich

CEO

Jasper Ehrenhorst

CFO

Jan Koch

Analyst, Deutsche Bank

Sarah Roberts

Analyst, Barclays

Olivier Calvé

Analyst, UBS

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Redcare Pharmacy N.v..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.355 -- 00:00:03.957 A very warm welcome to everybody from my side. 00:00:03.957 -- 00:00:09.740 Before we get into our presentation today, I would like to give some initial statements. 00:00:09.740 -- 00:00:14.802 First of all, we announced on the 26th of September that Jasper has stepped down as 00:00:14.802 -- 00:00:20.105 CFO of Redcar, but will remain with the company until the end of the year 00:00:20.105 -- 00:00:25.307 for a smooth transition. As part of this smooth transition, Jasper and myself 00:00:25.307 -- 00:00:29.953 will today make this on-earning call like we did also in the past. 00:00:29.953 -- 00:00:35.236 Yeah. Secondly, we also announced on the 26th of September that we will 00:00:35.236 -- 00:00:38.018 present a successor rather soon. 00:00:38.018 -- 00:00:43.501 This statement still holds true. Please be aware that due to strict market regulations, 00:00:43.501 -- 00:00:48.223 we cannot give any additional information on this topic today. 00:00:48.223 -- 00:00:53.786 And number three, as you have seen the development of our share price 00:00:53.786 -- 00:00:58.937 this year, as you can imagine, we are not satisfied with this at all. 00:00:58.937 -- 00:01:04.220 and we take it very serious. To us, it is an incentive to continue to deliver 00:01:04.220 -- 00:01:08.763 on our strategy and execution and to deliver results. 00:01:08.763 -- 00:01:13.807 We want to use this earning call also to bring three key messages across. 00:01:13.807 -- 00:01:18.850 First of all, we are scaling RX across the entire P&L from 00:01:18.850 -- 00:01:21.992 top line to full results. 00:01:21.992 -- 00:01:27.255 Secondly, we are strengthening our already positive operating cash flow 00:01:27.255 -- 00:01:31.516 and are fully funded to execute on our st...